Patents by Inventor Malcolm King

Malcolm King has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11625061
    Abstract: Two clocks, a fast clock and a slow clock are provided for clocking a processing unit. A plurality of frequency settings, referred to as gears, are defined for the two clock. Each of these gears indicates a maximum frequency for the fast clock and a minimum frequency for the slow clock, such that the gap between the two frequencies may be kept to a manageable level so as to reduce transients upon switching between the two clocks. The system switches between the gears as required. In response to a determination to increase the frequency of the clock signal, a higher gear is selected at which the maximum and minimum frequencies defined for that gear are higher than the previous selected gear.
    Type: Grant
    Filed: June 16, 2021
    Date of Patent: April 11, 2023
    Assignee: GRAPHCORE LIMITED
    Inventors: Simon Douglas Chambers, Stephen Felix, Ian Malcolm King
  • Patent number: 11614789
    Abstract: A system and method for docking a processing unit provided. According to the method, the system dithers between the two signals provided by the two clock generators so as to clock the processing unit at an average clock frequency having a value between the frequencies of the two signals. The average clock frequency is adjusted by modifying the proportion of time spent on one clock signal vs the other clock signal.
    Type: Grant
    Filed: June 17, 2021
    Date of Patent: March 28, 2023
    Assignee: GRAPHCORE LIMITED
    Inventor: Ian Malcolm King
  • Patent number: 11479546
    Abstract: The application relates to a series of 2-imino-6-methylhexahydropyrimidin-4-one derivatives and 3-imino-5-methyl-1,2,4-thiadiazinane 1,1-dioxide derivatives of formula (I), substituted by an arylaminophenyl or heteroarylaminophenyl moiety. The compounds are potent inhibitors of the growth and propagation of the Plasmodium falciparum parasite in human blood and thus useful as pharmaceutical agents for the treatment of malaria.
    Type: Grant
    Filed: April 2, 2019
    Date of Patent: October 25, 2022
    Inventors: Teresa De Haro Garcia, Lloyd Malcolm King, Martin Alexander Lowe, Malcolm Maccoss, Richard David Taylor, Zhaoning Zhu
  • Publication number: 20220019276
    Abstract: A system and method for docking a processing unit provided. According to the method, the system dithers between the two signals provided by the two clock generators so as to clock the processing unit at an average clock frequency having a value between the frequencies of the two signals. The average clock frequency is adjusted by modifying the proportion of time spent on one clock signal vs the other clock signal.
    Type: Application
    Filed: June 17, 2021
    Publication date: January 20, 2022
    Inventor: Ian Malcolm KING
  • Publication number: 20220019257
    Abstract: Two clocks, a fast clock and a slow clock are provided for clocking a processing unit. A plurality of frequency settings, referred to as gears, are defined for the two clock. Each of these gears indicates a maximum frequency for the fast clock and a minimum frequency for the slow clock, such that the gap between the two frequencies may be kept to a manageable level so as to reduce transients upon switching between the two clocks. The system switches between the gears as required. In response to a determination to increase the frequency of the clock signal, a higher gear is selected at which the maximum and minimum frequencies defined for that gear are higher than the previous selected gear.
    Type: Application
    Filed: June 16, 2021
    Publication date: January 20, 2022
    Inventors: Simon Douglas CHAMBERS, Stephen FELIX, Ian Malcolm KING
  • Publication number: 20210094941
    Abstract: The application relates to a series of 2-imino-6-methylhexahydropyrimidin-4-one derivatives and 3-imino-5-methyl-1,2,4-thiadiazinane 1,1-dioxide derivatives of formula (I), substituted by an arylaminophenyl or heteroarylaminophenyl moiety. The compounds are potent inhibitors of the growth and propagation of the Plasmodium falciparum parasite in human blood and thus useful as pharmaceutical agents for the treatment of malaria.
    Type: Application
    Filed: April 2, 2019
    Publication date: April 1, 2021
    Inventors: Teresa De Haro Garcia, Lloyd Malcolm King, Martin Alexander Lowe, Malcolm Maccoss, Richard David Taylor, Zhaoning Zhu
  • Publication number: 20070275091
    Abstract: The invention relates to compositions and methods for enhancing mucus functions such as but not limited to improved respiratory tract mucus clearance. The compositions of the invention are mucothickening compositions. They can be used to improve mucus clearance in a subject in need thereof, such as in the treatment of conditions related to non-functioning cilia or to excessively thin mucus.
    Type: Application
    Filed: March 30, 2005
    Publication date: November 29, 2007
    Inventors: Malcolm King, Gustavo Zayas
  • Publication number: 20040224922
    Abstract: The present invention is for a charged dextran, preferably dextran sulfate, as an improved mucoactive agent which can be used to improve viscoelasticity and clearance of respiratory tract mucus. The charged dextran can be used in the treatment of animals with impaired mucus clearance, mucus retention and/or mucus hypersecretion, such as cystic fibrosis, chronic bronchitis, bronchiectasis, bronchiolitis and bronchial asthma. Related methods of treatment and pharmaceutical compositions, particularly aerosolized dextran sulfate compositions are encompassed within the scope of the invention.
    Type: Application
    Filed: February 23, 2004
    Publication date: November 11, 2004
    Inventor: Malcolm King
  • Publication number: 20020032172
    Abstract: This invention relates to the use of polysaccharide such as dextran to improve mucus clearance. In the present invention, dextran has been shown to reduce viscoelasticity and increase mucus clearability of sputum of cystic fibrosis patients. Dextran also reduced viscoelasticity of healthy dog mucus. The present invention therefore may be used to improve mucus clearance in cystic fibrosis patients and treat other conditions associated with defect in airway mucus clearance including chronic bronchitis, bronchiectasis and bronchial asthma.
    Type: Application
    Filed: June 28, 2001
    Publication date: March 14, 2002
    Inventors: Malcolm King, David P. Speert
  • Patent number: 6339075
    Abstract: This invention relates to the use of polysaccharide such as dextran to improve mucus clearance. In the present invention, dextran has been shown to reduce viscoelasticity and increase mucus clearability of sputum of cystic fibrosis patients. Dextran also reduced viscoelasticity of healthy dog mucus. The present invention therefore may be used to improve mucus clearance in cystic fibrosis patients and treat other conditions associated with defect in airway mucus clearance including chronic bronchitis, bronchiectasis and bronchial asthma.
    Type: Grant
    Filed: March 31, 1998
    Date of Patent: January 15, 2002
    Assignees: The University of British Columbia, The University of Alberta
    Inventors: Malcolm King, David P Speert
  • Patent number: 5802600
    Abstract: A data processing system dynamically balances allocation of storage areas in a shared coupling facility that is devoted to storage of directory entries and data blocks. Each directory entry includes information regarding the validity of a data block that is locally stored by one or more processor modules in the data processing system. The system includes a coupling facility having a cache memory wherein a first portion is allocated to storage of data blocks and a second portion is allocated to storage of directory entries. Each directory entry, associated with a data block, indicates the validity or invalidity of data contained in a copy of the data block maintained by a connected computer module in its local memory. Each computer module, upon requiring a first data block and determining that (i) the first data block is present in its local memory (i.e., a buffer "hit"), but (ii) is not marked valid and (iii) is not present in the coupling facility (i.e.
    Type: Grant
    Filed: November 12, 1996
    Date of Patent: September 1, 1998
    Assignee: International Business Machines Corporation
    Inventors: Kevin Frank Smith, Kelly Carpenter, Gary Malcolm King